⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL133136 | 1.00 | — | — | |
| SCHEMBL585520 | 0.94 | — | — | |
| SCHEMBL10527801 | 0.94 | — | — | |
| SCHEMBL1139908 | 0.94 | — | — | |
| SCHEMBL3756290 | 0.94 | — | — | |
| SCHEMBL3198984 | 0.94 | — | — | |
| SCHEMBL1140387 | 0.94 | — | — | |
| SCHEMBL16534583 | 0.94 | — | — | |
| SCHEMBL180919 | 0.94 | — | — | |
| SCHEMBL563490 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023120358-A1 | PRODUCTION METHOD FOR COMPOUND | 住友化学株式会社 | 2023-06-29 | — | — | WO | disclosed |
| EP-3374350-B1 | HYDROXYPYRIDINONE AND HYDROXYPYRIMIDINONE BASED COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | FORGE THERAPEUTICS INC (US) | 2022-01-05 | — | — | EP | disclosed |
| US-11005108-B2 | Molecularly tunable heterogeneous catalysts by edge functionalization of graphitic carbons | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-05-11 | — | — | US | disclosed |
| US-20210078957-A1 | SUBSTITUTED PYRIMIDINES FOR TREATING BACTERIAL INFECTIONS | FORGE THERAPEUTICS, INC. | 2021-03-18 | — | — | US | disclosed |
| US-10875832-B2 | Substituted pyrimidines for treating bacterial infections | FORGE THERAPEUTICS, INC. (US) | 2020-12-29 | — | — | US | disclosed |
| US-10611747-B2 | Pyrone based compounds for treating bacterial infections | FORGE THERAPEUTICS, INC. (US) | 2020-04-07 | — | — | US | disclosed |
| US-10414735-B2 | Substituted hydroxypyrimidinones for treating bacterial infections | FORGE THERAPEUTICS, INC. (US) | 2019-09-17 | — | — | US | disclosed |
| EP-2331560-B1 | PEPTIDES USEFUL IN THE TREATMENT AND/OR CARE OF SKIN, MUCOUS MEMBRANES, SCALP AND/OR HAIR AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS | LIPOTEC SA (ES) | 2019-05-08 | — | — | EP | disclosed |
| US-20180327365-A1 | HYDROXYPYRIDINONE AND HYDROXYPYRIMIDINONE BASED COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | BLACKSMITH MEDICINES, INC. | 2018-11-15 | — | — | US | disclosed |
| US-20180319761-A1 | PYRONE BASED COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | BLACKSMITH MEDICINES, INC. | 2018-11-08 | — | — | US | disclosed |
| US-7667040-B2 | Azacyclic ethynyl derivatives | NEUROSEARCH A/S (DK) | 2010-02-23 | — | — | US | disclosed |
| WO-2009106343-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING METALLOPROTEINASE INHIBITORS | LIPOTEC, S.A. (ES) | 2009-09-03 | — | — | WO | disclosed |
| WO-2009026701-A1 | SIRTUIN INHIBITORS | METHYLGENE INC. (CA) | 2009-03-05 | — | — | WO | disclosed |
| US-20080188519-A1 | Novel azacyclic ethynyl derivatives | ANIONA APS (DK) | 2008-08-07 | — | — | US | disclosed |
| US-20080188670-A1 | 1,4-Dithienylbenzene Derivative | NAT. INST. OF ADVANCED INDUSTRIAL SCI. AND TECH. (JP) | 2008-08-07 | — | — | US | disclosed |
| EP-1506205-B1 | NOVEL AZACYCLIC ETHYNYL DERIVATIVES | NEUROSEARCH AS (DK) | 2008-07-16 | — | — | EP | disclosed |
| US-7378526-B2 | Azacyclic ethynyl derivatives | NEUROSEARCH A/S (DK) | 2008-05-27 | — | — | US | disclosed |
| US-20050171078-A1 | Novel azacyclic ethynyl derivatives | NEUROSEARCH (DK) | 2005-08-04 | — | — | US | disclosed |
| EP-1506205-A2 | NOVEL AZACYCLIC ETHYNYL DERIVATIVES | NEUROSEARCH A/S (DK) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003094830-A2 | NOVEL AZACYCLIC ETHYNYL DERIVATIVES | NEUROSEARCH A/S (DK) | 2003-11-20 | — | — | WO | disclosed |